The largest database of trusted experimental protocols

Osteosoft decalcifier solution

Manufactured by Merck Group
Sourced in United States

Osteosoft decalcifier solution is a laboratory product designed for the decalcification of bone and other calcified tissue samples. It is a chemical solution used to remove calcium salts from specimens, enabling easier sectioning and analysis.

Automatically generated - may contain errors

2 protocols using osteosoft decalcifier solution

1

Histological Evaluation of Scaffold Implants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Morphology was studied following standard histological procedures (10 (link), 11 (link)). Briefly, articular specimens were fixed (4% formaldehyde, 5 days) and immersed in Osteosoft decalcifier solution (Merck) for 5 to 8 weeks. Then, samples were embedded in paraffin, 5-μm-thick serial sections were obtained in the middle part of the scaffolds (~3 mm diameter), and stained with hematoxylin-eosin and Masson's trichrome. The presence of chondral glycosaminoglycan was monitored by Alcian blue staining (pH 2.5) and counterstained with Harris hematoxylin. Sections were analyzed under a Leica-DM4000B optical microscope, and pictures were taken using a camera (Leica-DFC420). Cell density (number of cells/mm2) was quantified inside the implanted scaffolds as well as the distance between articular surface and scaffold, using Image proPlus 7.0 (Media Cybernetics). Results are expressed as average values ± SD of 4 measurements. Results were compared using Mann-Whitney U-test, and were considered statistically significant when the p value was <0.05. The square of the Pearson correlation coefficient (R2) was used to determine the degree of linear regression between the parameters studied.
+ Open protocol
+ Expand
2

Histological Evaluation of Rat Joints

Check if the same lab product or an alternative is used in the 5 most similar protocols
After micro-CT analysis, the hind paws and tails of the rats were decalcified with OsteoSoft decalcifier solution (no. 101728; Merck, Burlington, MA, USA) and embedded in paraffin. Five micrometer sections were stained for hematoxylin and eosin (H&E) or Safranin O Fast Green. For H&E staining, sections were incubated in Mayer’s hematoxylin (no. MHS16) and Eosin Y solution (no. HT110116) (both from Sigma, St. louis, MO, USA). For Safranin O Fast Green staining, sections were incubated in Weigert’s iron hematoxylin (no. HT1079), 0.1% fast green FCF (no. F7252), and 0.1% Safranin O solution (no. HT90432) (all from Sigma, St. louis, MO, USA). The sections were subsequently dehydrated and embedded in Entellan (no. 1.07961.0100; Merck, Burlington, MA, USA). Separate experimentally blinded observers scored the caudal spine, calcaneus, and tarsal regions semi-quantitatively (0–4) for inflammation, bone proliferation and pannus formation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!